Silence Therapeutics (SLN) Tax Rate (2024 - 2025)
Silence Therapeutics recorded quarterly Tax Rate of 0.0% in Q3 2025, up 86.95% quarter-over-quarter from 0.04% in Q2 2025, and up 13.0% year-over-year from 0.0% in Q3 2024.
Silence Therapeutics' Tax Rate history runs 2 years deep, the most recent figure standing at 0.0% for Q3 2025.
- In Q3 2025, Tax Rate rose 13.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.01% (up 83.0% YoY), while the FY2025 annual figure was 0.01%, up 189.0% from the prior year.
- Tax Rate came in at 0.0% for Q3 2025 at Silence Therapeutics, up from 0.04% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 2.57% in Q4 2024 to a low of 11.8% in Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 57.14 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 5.61 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 17.68 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -6.79 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 12.51 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7.07 |
| 10 | Silence Therapeutics | 924.61 Mn | 854.53 Mn | 411,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 0.00 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | -0.04 |
| Jun 30, 2025 | -0.04 |
| Dec 31, 2024 | 2.57 |
| Dec 31, 2024 | 2.57 |
| Sep 30, 2024 | -0.14 |
| Sep 30, 2024 | -0.14 |
| Jun 30, 2024 | -1.17 |
| Jun 30, 2024 | -1.17 |
| Mar 31, 2024 | -11.80 |
| Mar 31, 2024 | -11.80 |